HealthQuill Medical
Amgen Inc. will expand its Ohio biomanufacturing facility for $900 million, after a recent move to invest $1 billion to build a second manufacturing plant in Holly Springs, North Carolina, US.
Drugs Medical Pharma

Amgen to invest $900 million in Ohio biomanufacturing facility

HQ Team April 26, 2025: Amgen Inc. will expand its Ohio biomanufacturing facility for $900 million, after a recent move to invest $1 billion to.

Read More
Swiss healthcare multinational F. Hoffmann-La Roche AG will invest $50 billion in the US over the next five years to expand its research and manufacturing facilities.
Drugs Medical Pharma

Roche to invest $50 billion in US over next five years to expand capacity

HQ Team April 22, 2025: Swiss healthcare multinational F. Hoffmann-La Roche AG will invest $50 billion in the US over the next five.

Read More
Escalating hostilities and limited access to medical supplies are exacerbating an already dire humanitarian crisis in Gaza depriving civilians of shelter, food and medicine, the UN warns.
Drugs Health Medical

Dire humanitarian crisis engulfs Gaza Strip, displaced people swell: UN 

HQ Team April 17, 2025: Escalating hostilities and limited access to medical supplies are exacerbating an already dire humanitarian crisis in Gaza depriving.

Read More
Austria’s Cyprumed GmbH has announced a license and option agreement with Merck & Co., to develop oral formulations of the US-based company’s peptides for an upfront payment of $493 million.
Drugs Health Medical

Austria’s Cyprumed in $493 million pact with Merck to develop peptides

HQ Team April 17, 2025: Austria’s Cyprumed GmbH has announced a license and option agreement with Merck & Co., to develop oral formulations.

Read More
Bristol Myers Squibb’s end-phase trial to test a drug for treating a heart condition, where the muscle of the heart's main pumping chamber becomes abnormally thickened, has failed to meet its goals.
Drugs Health Medical

Bristol Myers’ test drug to treat a type of heart disease fails to meet goals

HQ Team April 15, 2025: Bristol Myers Squibb’s end-phase trial to test a drug for treating a heart condition, where the muscle of.

Read More
Cambridge researchers have invented a device to record heart sounds accurately and diagnose coronary valve diseases better than traditional stethoscopes.
Health Medical Pharma

Cambridge develops handheld device to detect faulty heart valves

HQ Team April 13, 2025: Cambridge researchers have invented a device to record heart sounds accurately and diagnose coronary valve diseases better than.

Read More
Johnson & Johnson MedTech’s arm, Shockwave Medical Inc. has started human trials to assess the effectiveness of its coronary intravascular catheter for treating blocked arteries, according to a statement.
Health Medical Pharma

J&J starts trial on coronary pressure wave catheter to clear artery blocks

HQ Team April 13, 2025: Johnson & Johnson MedTech’s arm, Shockwave Medical Inc. has started human trials to assess the effectiveness of its.

Read More
A European Space Agency satellite is slated for launch on April 29 to gather information about the state of global forests and how they are changing.
Climate Health Medical

European Space Agency set to launch satellite to map global forests

HQ Team April 12, 2025: A European Space Agency satellite is slated for launch on April 29 to gather information about the state.

Read More
A landmark deal to reduce greenhouse emissions from global shipping is set to be formally adopted in October before coming into force in 2027.
Climate Health Medical

Historic deal to cut global shipping emissions may take effect in 2027

HQ Team April 12, 2025: A landmark deal to reduce greenhouse emissions from global shipping is set to be formally adopted in October.

Read More
Novo Nordisk will invest 6.4 billion reais ($1.05 billion) in Brazil’s Monte Claros to expand its production of injectable treatments for people living with obesity and chronic diseases.
Drugs Medical Pharma

Novo Nordisk to invest $1.05b in Monte Claros facility in Brazil

HQ Team April 10, 2025: Novo Nordisk will invest 6.4 billion reais ($1.05 billion) in Brazil’s Monte Claros to expand its production of.

Read More